The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #32166 · Form 4 · 0001493152-26-046201

PALISADE BIO, INC. · Exercise / conversion · Common Stock

PALISADE BIO, INC. · Transacted October 6, 2026 · Filed October 7, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for PALISADE BIO, INC. records an exercise / conversion involving Common Stock on October 6, 2026. The reported quantity was 3,227,384. The filing date is October 7, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001357459
Security type
Non-derivative
Acquisition type
Exercise / conversion · Code M
Quantity acquired
3,227,384
Reported price
Not reported · See footnotes
Reference value
Not reported
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
3,356,672
Ownership description
Not reported
SEC acceptance time
Oct 7, 2026, 9:35 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

PALI · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
F2
Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs.
F3
The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.
F4
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F5
The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
F6
The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.